06.16.15
Cambridge, Mass.-based InVivo Therapeutics Holdings Corp. has appointed independent board director Ann Merrifield to the newly created position of lead director. The lead director will serve as a liaison between the chairman and non-management directors, chair all executive sessions, and work with the chairman on meeting agendas and time schedules for the board of directors.
“Ann Merrifield’s deep industry knowledge and expertise has proven to be invaluable since joining the Board of Directors in November 2014,” said CEO and Chairman Mark Perrin. “Her proven leadership capabilities make her an excellent choice for Lead Director, and I look forward to working closely with her.”
The company’s board of directors also approved splitting the governance, nominating, and compensation committee into two committees: the nominating and corporate governance committee and the compensation committee. Ann Merrifield has been appointed as the new chairwoman of the former. Kenneth DiPietro will serve as Chairman of the newly created compensation committee, and John McCarthy, Jr. will continue to serve as the audit committee chairman.
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.
“Ann Merrifield’s deep industry knowledge and expertise has proven to be invaluable since joining the Board of Directors in November 2014,” said CEO and Chairman Mark Perrin. “Her proven leadership capabilities make her an excellent choice for Lead Director, and I look forward to working closely with her.”
The company’s board of directors also approved splitting the governance, nominating, and compensation committee into two committees: the nominating and corporate governance committee and the compensation committee. Ann Merrifield has been appointed as the new chairwoman of the former. Kenneth DiPietro will serve as Chairman of the newly created compensation committee, and John McCarthy, Jr. will continue to serve as the audit committee chairman.
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.